The prophylactic use of C1 inhibitor in hereditary angioedema patients undergoing invasive surgical procedures: a retrospective study

Table 2 Medications approved for the treatment of acute HAE attacks

Treatment of acute attacks
Medication class	Example	Dose	Approval
Medication class	Example	Dose	Canada	US	Europe
C1 INH Replacement (plasma derived)	Berinert	20 U/kg IV	✓	✓	✓
	Cetor	1000 U IV			✓
	Cinryze	1000 U IV			✓
Recombinant C1 INH	Ruconest	50 U/kg IV			✓
Recombinant C1 INH	Rhucin	50 U/kg IV		Pending
Kallikrein Inhibitor	Ecallantide	30 mg SC		✓
Bradykinin antagonist	Icatibant	30 mg SC	Pending	✓	✓

ISSN: 1710-1492